145 related articles for article (PubMed ID: 35305420)
21. RhoJ facilitates angiogenesis in glioblastoma via JNK/VEGFR2 mediated activation of PAK and ERK signaling pathways.
Wang M; Zhang C; Zheng Q; Ma Z; Qi M; Di G; Ling S; Xu H; Qi B; Yao C; Xia H; Jiang X
Int J Biol Sci; 2022; 18(3):942-955. PubMed ID: 35173528
[TBL] [Abstract][Full Text] [Related]
22. Autocrine VEGFR1 and VEGFR2 signaling promotes survival in human glioblastoma models in vitro and in vivo.
Szabo E; Schneider H; Seystahl K; Rushing EJ; Herting F; Weidner KM; Weller M
Neuro Oncol; 2016 Sep; 18(9):1242-52. PubMed ID: 27009237
[TBL] [Abstract][Full Text] [Related]
23. Andrographolide inhibits tumor angiogenesis via blocking VEGFA/VEGFR2-MAPKs signaling cascade.
Shen K; Ji L; Lu B; Xu C; Gong C; Morahan G; Wang Z
Chem Biol Interact; 2014 Jul; 218():99-106. PubMed ID: 24814888
[TBL] [Abstract][Full Text] [Related]
24. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
25. Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway.
Li B; Zhang Y; Yin R; Zhong W; Chen R; Yan J
Mediators Inflamm; 2020; 2020():1649453. PubMed ID: 33162828
[TBL] [Abstract][Full Text] [Related]
26. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
27. Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.
Yang J; Wang Q; Qiao C; Lin Z; Li X; Huang Y; Zhou T; Li Y; Shen B; Lv M; Feng J
Cell Mol Immunol; 2014 May; 11(3):285-93. PubMed ID: 24608894
[TBL] [Abstract][Full Text] [Related]
28. The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.
Atzori MG; Tentori L; Ruffini F; Ceci C; Bonanno E; Scimeca M; Lacal PM; Graziani G
J Pharmacol Exp Ther; 2018 Jan; 364(1):77-86. PubMed ID: 29025978
[TBL] [Abstract][Full Text] [Related]
29. Quercetin-4'-O-β-D-glucopyranoside (QODG) inhibits angiogenesis by suppressing VEGFR2-mediated signaling in zebrafish and endothelial cells.
Lin C; Wu M; Dong J
PLoS One; 2012; 7(2):e31708. PubMed ID: 22348123
[TBL] [Abstract][Full Text] [Related]
30. Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency.
Barzaman K; Samadi M; Moradi-Kalbolandi S; Majidzadeh-A K; Salehi M; Jalili N; Jazayeri MH; Khorammi S; Darvishi B; Siavashi V; Shekarabi M; Farahmand L
Exp Cell Res; 2021 Aug; 405(2):112685. PubMed ID: 34090863
[TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
32. Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.
Navone SE; Guarnaccia L; Cordiglieri C; Crisà FM; Caroli M; Locatelli M; Schisano L; Rampini P; Miozzo M; La Verde N; Riboni L; Campanella R; Marfia G
World Neurosurg; 2018 Dec; 120():e380-e391. PubMed ID: 30144594
[TBL] [Abstract][Full Text] [Related]
33. Xanthatin, a novel potent inhibitor of VEGFR2 signaling, inhibits angiogenesis and tumor growth in breast cancer cells.
Yu Y; Yu J; Pei CG; Li YY; Tu P; Gao GP; Shao Y
Int J Clin Exp Pathol; 2015; 8(9):10355-64. PubMed ID: 26617743
[TBL] [Abstract][Full Text] [Related]
34. Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells.
Xing Y; Tu J; Zheng L; Guo L; Xi T
Oncol Rep; 2015 Jan; 33(1):163-70. PubMed ID: 25376085
[TBL] [Abstract][Full Text] [Related]
35. Asiatic acid inhibits angiogenesis and vascular permeability through the VEGF/VEGFR2 signaling pathway to inhibit the growth and metastasis of breast cancer in mice.
Tian M; Chen K; Huang J; Chu D; Li J; Huang K; Ma C
Phytother Res; 2021 Nov; 35(11):6389-6400. PubMed ID: 34541711
[TBL] [Abstract][Full Text] [Related]
36. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Pang X; Yi Z; Zhang X; Sung B; Qu W; Lian X; Aggarwal BB; Liu M
Cancer Res; 2009 Jul; 69(14):5893-900. PubMed ID: 19567671
[TBL] [Abstract][Full Text] [Related]
37. α-Melanocyte-stimulating hormone inhibits angiogenesis through attenuation of VEGF/VEGFR2 signaling pathway.
Weng WT; Huang SC; Ma YL; Chan HH; Lin SW; Wu JC; Wu CY; Wen ZH; Wang EM; Wu CL; Tai MH
Biochim Biophys Acta; 2014 Jun; 1840(6):1850-60. PubMed ID: 24530634
[TBL] [Abstract][Full Text] [Related]
38. AMG232 inhibits angiogenesis in glioma through the p53-RBM4-VEGFR2 pathway.
Xiao Y; Li M; Ma T; Ning H; Liu L
J Cell Sci; 2023 Jan; 136(2):. PubMed ID: 36601864
[TBL] [Abstract][Full Text] [Related]
39. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA
Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055
[TBL] [Abstract][Full Text] [Related]
40. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.
Xie C; Wan X; Quan H; Zheng M; Fu L; Li Y; Lou L
Cancer Sci; 2018 Apr; 109(4):1207-1219. PubMed ID: 29446853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
